Anti-proliferative effect of Pleurotus tuberregium against colon and cervical cancer cells

Journal of Medicinal Plant Research

Volumn 5, Issue 30, 2011, Pages 6650-6655

  Maness, L ^a   Sneed, N ^a   Hardy, B ^a   Yu, J ^a   Ahmedna, M ^b   Goktepe, I ^a  

^a North Carolina and State University   (United States)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

Author keywords

Alternative medicine; Antiproliferation; Colon and cervical cancer; Complementary; Pleurotus tuberregium

Indexed keywords

ALCOHOL; MITOMYCIN C; PLANT EXTRACT; PLEUROTUS TUBERREGIUM EXTRACT; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; PLEUROTUS; PLEUROTUS TUBERREGIUM; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

EID: 84892079297     PISSN: None     EISSN: 19960875     Source Type: Journal    
DOI: 10.5897/JMPR11.457     Document Type: Article

References (22)

1. American Cancer Society (2009). Statistics, Cancer facts and figures (2009). http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2009_Presentation.asp.
2. Abenavoli L, Bardazzi G, Cracolici F, Quaranta C, Santini G, Graziosi S, Polero L, Leggio L, Addolorato G (2008). Complementary therapies for treating alcoholism: First Annual meeting by Complementary Medicine Research Group of the Italian Society for Alcohol Studies--May 5, 2006, Florence, Italy. Fitoterapia, 79(2): 142-147.
3. Baldwin EL, Osheroff N (2005). Etoposide, topoisomerase II and cancer. Curr. Med. Chem-Anti-Cancer Agents, 5: 363-372.
4. Baliga MS (2010). Alstonia scholaris Linn R Br in the treatment and prevention of cancer: past, present, and future. Integr. Cancer Ther., 9(3): 261-269.
5. Borchers AT, Keen CL, Gershwin ME (2004). Mushrooms, tumors, and immunity: an update. Exp. Biol. Med., 229(5): 393-406.
6. Cassileth BR, Deng G (2004). Complementary and alternative therapies for cancer. Oncologist, 9(1): 80-89.
7. Deng G, Cassileth BR (2005). Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA. Cancer J. Clin., 55(2): 109-116.
8. Fang N, Li Q, Yu S, Zhang J, He L, Ronis M, Badger T (2006). Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from Shiitake Mushrooms. J. Altern. Compl. Med., 12(2): 125-132.
9. Grube BJ, Eng ET, Kao Y, Kwon A, Chen S (2001). White Button Mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J. Nutr., 131(12): 3288-3293.
10. Lam YW, Ng TB, Wang HX (2001). Antiproliferative and antimitogenic activities in a peptide from puffball mushroom Calvatia caelata. Biochem. Biophys. Res. Commun., 289(3): 744-749.
11. Lavi I, Dana F, Shimona G, Yitzhak H, Schwartz B (2006). An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett., 244(1): 61-70.
12. Lee BC, Bae JT, Pyo HB, Choe TB, Kim SW, Hwang HJ, Yun JW (2003). Biological activities of the polysaccharides produced from submerged culture of the edible Basidiomycete Grifola frondosa. Enzyme Microb. Technol., 32(5): 574-581.
13. Lucier G, Allhouse J, Lin B (2003). Factors affecting U.S. mushroom consumption. USDA Electronic Outlook Report from the Economic Research Service. VGS 295-01.
14. Motoi M, Goto S, Ohno N (2003). Structure and antitumor activity of 1,3b-glucan from cultivated fruit bodies of culinary-medicinal mushroom Hypsizygus marmoreus (Peck) bigel. (Agaricomycetideae). Int. J. Med. Mushrooms, 5(3): 14.
15. Nahin, RL, Barnes PM, Stussman BJ, Bloom B (2009). Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States, 2007. National Health Statistics Reports; No 18. Hyattsville, MD: National Center for Health Statistics.
16. Norikura T, Fujiwara K, Narita T, Yamaguchi S, Morinaga Y, Iwai K, Matsue H. (2011). Anticancer Activities of Thelephantin O and Vialinin A Isolated from Thelephora aurantiotincta. J. Agric. Food Chem., 59(13): 6974-6979.
17. Tao Y, Zhang Y, Zhang L (2009). Chemical modification and antitumor activities of two polysaccharide-protein complexes from Pleurotus tuber-regium. Int. J. Biol. Macromol., 45(2): 109-115.
18. Wang L, Weller C (2006). Recent advances in extraction of nutraceuticals from plants. Trends Food Sci. Technol., 17(6): 300-312.
19. Wasser S (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol., 60: 258-274.
20. Wong K, Cheung P (2008). Sclerotium of culinary-medicinal King Tuber Oyster Mushroom, Pleurotus tuberregium (Fr.) Singer (Agaricomycetideae): Its cultivation, biochemical composition, and biopharmacological effects (Review). Int. J. Med. Mushrooms, 10(4): 303-313.
21. Zhang M, Cheung P, Zhang L (2001). Evaluation of mushroom dietary fiber (nonstarch polysaccharides) from sclerotia of Pleurotus tuber-regium (Fries) singer as a potential antitumor agent. J. Agric. Food Chem., 49: 5059-5062.
22. Zhang M, Cui S, Cheung P, Wang Q (2007). Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci. Technol., 18(1): 4-19.